4DB-11636-32273
2 vaccinations
1 coded response
11 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 070 / NJ
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Dose 1 — Moderna
-
2021-01-08
Registered in v-safe
-
2021-01-09
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Dyspnoea, Fatigue, Feeding disorder, Headache, Injection site pain, Office visit, Pain, SARS-CoV-2 test positive — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Yes- I received the vaccine 1/4. The severe pain at the site lasted 24-hours 48 hours. Chills, body aches, headache and severe fatigue onset within 12 hours of vaccine. I was unable to eat or drink from 1/5-1/7 and was sent to urgent care: tested positive for Covid. On 1/9 my symptoms have improved- able to eat and drink. First time noticing shortness of breath when taking stairs. Resting PO2= 96%.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-03
Dose 2 — Moderna
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-08-04
- 2022-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Yes- I received the vaccine 1/4. The severe pain at the site lasted 24-hours 48 hours. Chills, body aches, headache and severe fatigue onset within 12 hours of vaccine. I was unable to eat or drink from 1/5-1/7 and was sent to urgent care: tested positive for Covid. On 1/9 my symptoms have improved- able to eat and drink. First time noticing shortness of breath when taking stairs. Resting PO2= 96%.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Feeding disorder | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Office visit | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release